Atlas Trials

Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke

Clinical trial NCT06587347 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06587347
Sponsor
Capital Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute StrokeIschemic Stroke, AcuteCerebral Infarction
Start date
2024-11-20
Primary completion
2026-06-30
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.